Genetic test could be used to 'personalise' drugs, say scientists

Patients' genes would be checked to see whether treatments work for them

Scientists are developing a genetic test that may tell the difference between cancer patients who are likely to respond to treatment with a powerful anti-tumour drug and those people for whom the drug will be useless.

The test should allow doctors to prescribe drugs only to those people who are likely to benefit from the medicines rather than giving them – and their side-effects – to a wide range of patients in the knowledge that only some individuals will respond to the treatment.

A way of distinguishing between patients who are "responders" and "non-responders" to drugs is seen as one of the most important developments in modern medicine. "Personalised" treatment based on the analysis of a person's DNA is considered one of the key achievements that will emerge from the decoding of the human genome.

The researchers have identified six genes that are critical to the proper functioning of the anti-cancer drug paclitaxel, known by the brand name Taxol, which is widely used in the treatment of breast cancer prior to surgery.

If any of the six genes are "faulty", paclitaxel does not work and the tumour cells continue to divide uncontrollably, just as they would without treatment, the scientists said. About 15 per cent of the 45,000 women diagnosed with breast cancer each year in Britain are given paclitaxel, but a significant proportion do not respond to treatment and this is only apparent after the drug has been used for some time.

Many drugs in all branches of medicine are given knowing that they are only likely to work on a proportion of the population because of genetic differences between individuals. The idea is that the new test will be able to identify patients with any of the six faulty genes so that they could be spared the ordeal of being given paclitaxel, which can cause side-effects including immune suppression and nausea.

Although the research has only been performed on human cancer cells growing in the test tube, the scientists believe that the findings, published in the journal Lancet Oncology, can now be rapidly developed into a clinical test so that it can be used on breast cancer patients within five or seven years.

"A great challenge in cancer medicine is determining which patients will benefit from particular drugs and it is hoped that this research is a step towards more rapid developments in this type of personalised medicine," said Dr Charles Swanton, head of translational cancer therapeutics at Cancer Research UK.

The paclitaxel study focused on genetic differences between the patients' cancer cells that came about as a result of the tumour's development. It is hoped that inherited differences in the DNA of people could also be used to distinguish between responders and non-responders to a particular drug.

"The challenge is to apply these methods to other drugs in cancer medicine to help identify new drugs within clinical trials that might benefit patients who are predicted to be unresponsive to treatment," Dr Swanton added.

The study, which found the six genes after scanning 829 of the 21,000 genes of the human genome, was a collaboration between the London Research Institute and the Technical University of Denmark.

Start your day with The Independent, sign up for daily news emails
PROMOTED VIDEO
ebooks
ebooksA year of political gossip, levity and intrigue from the sharpest pen in Westminster
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Ashdown Group: Client Services Manager - Relationship Management - London

£30000 - £32000 per annum + benefits : Ashdown Group: A highly successful, int...

Recruitment Genius: Credit Controller / Customer Service

£18000 - £20000 per annum: Recruitment Genius: This rapidly expanding business...

Recruitment Genius: Electronics Engineers / Senior Electronics Engineers

£25000 - £55000 per annum: Recruitment Genius: Based in Henley-on-Thames, this...

Austen Lloyd: Private Client Solicitor - Oxford

Excellent Salary : Austen Lloyd: OXFORD - REGIONAL FIRM - An excellent opportu...

Day In a Page

Syria crisis: Celebrities call on David Cameron to take more refugees as one young mother tells of torture by Assad regime

Celebrities call on David Cameron to take more Syrian refugees

One young mother tells of torture by Assad regime
The enemy within: People who hear voices in their heads are being encouraged to talk back – with promising results

The enemy within

People who hear voices in their heads are being encouraged to talk back
'In Auschwitz you got used to anything'

'In Auschwitz you got used to anything'

Survivors of the Nazi concentration camp remember its horror, 70 years on
Autumn/winter menswear 2015: The uniforms that make up modern life come to the fore

Autumn/winter menswear 2015

The uniforms that make up modern life come to the fore
'I'm gay, and plan to fight military homophobia'

'I'm gay, and plan to fight military homophobia'

Army general planning to come out
Iraq invasion 2003: The bloody warnings six wise men gave to Tony Blair as he prepared to launch poorly planned campaign

What the six wise men told Tony Blair

Months before the invasion of Iraq in 2003, experts sought to warn the PM about his plans. Here, four of them recall that day
25 years of The Independent on Sunday: The stories, the writers and the changes over the last quarter of a century

25 years of The Independent on Sunday

The stories, the writers and the changes over the last quarter of a century
Homeless Veterans appeal: 'Really caring is a dangerous emotion in this kind of work'

Homeless Veterans appeal

As head of The Soldiers' Charity, Martin Rutledge has to temper compassion with realism. He tells Chris Green how his Army career prepared him
Wu-Tang Clan and The Sexual Objects offer fans a chance to own the only copies of their latest albums

Smash hit go under the hammer

It's nice to pick up a new record once in a while, but the purchasers of two latest releases can go a step further - by buying the only copy
Geeks who rocked the world: Documentary looks back at origins of the computer-games industry

The geeks who rocked the world

A new documentary looks back at origins of the computer-games industry
Belle & Sebastian interview: Stuart Murdoch reveals how the band is taking a new direction

Belle & Sebastian is taking a new direction

Twenty years ago, Belle & Sebastian was a fey indie band from Glasgow. It still is – except today, as prime mover Stuart Murdoch admits, it has a global cult following, from Hollywood to South Korea
America: Land of the free, home of the political dynasty

America: Land of the free, home of the political dynasty

These days in the US things are pretty much stuck where they are, both in politics and society at large, says Rupert Cornwell
A graphic history of US civil rights – in comic book form

A graphic history of US civil rights – in comic book form

A veteran of the Fifties campaigns is inspiring a new generation of activists
Winston Churchill: the enigma of a British hero

Winston Churchill: the enigma of a British hero

A C Benson called him 'a horrid little fellow', George Orwell would have shot him, but what a giant he seems now, says DJ Taylor
Growing mussels: Precious freshwater shellfish are thriving in a unique green project

Growing mussels

Precious freshwater shellfish are thriving in a unique green project